GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heidelberg Pharma AG (XTER:HPHA) » Definitions » E10

Heidelberg Pharma AG (XTER:HPHA) E10 : €-0.64 (As of May. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Heidelberg Pharma AG E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Heidelberg Pharma AG's adjusted earnings per share data for the three months ended in May. 2024 was €-0.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.64 for the trailing ten years ended in May. 2024.

During the past 3 years, the average E10 Growth Rate was 9.00% per year. During the past 5 years, the average E10 Growth Rate was 19.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Heidelberg Pharma AG was 26.30% per year. The lowest was 9.00% per year. And the median was 22.40% per year.

As of today (2024-09-21), Heidelberg Pharma AG's current stock price is €2.35. Heidelberg Pharma AG's E10 for the quarter that ended in May. 2024 was €-0.64. Heidelberg Pharma AG's Shiller PE Ratio of today is .


Heidelberg Pharma AG E10 Historical Data

The historical data trend for Heidelberg Pharma AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heidelberg Pharma AG E10 Chart

Heidelberg Pharma AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.41 -0.89 -0.71 -0.66 -0.67

Heidelberg Pharma AG Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.66 - -0.67 -0.64 -0.64

Competitive Comparison of Heidelberg Pharma AG's E10

For the Biotechnology subindustry, Heidelberg Pharma AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heidelberg Pharma AG's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heidelberg Pharma AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Heidelberg Pharma AG's Shiller PE Ratio falls into.



Heidelberg Pharma AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Heidelberg Pharma AG's adjusted earnings per share data for the three months ended in May. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of May. 2024 (Change)*Current CPI (May. 2024)
=-0.09/125.7761*125.7761
=-0.090

Current CPI (May. 2024) = 125.7761.

Heidelberg Pharma AG Quarterly Data

per share eps CPI Adj_EPS
201408 0.209 99.823 0.263
201411 -0.153 99.543 -0.193
201502 -0.134 99.217 -0.170
201505 -0.086 100.417 -0.108
201508 -0.172 100.617 -0.215
201511 -0.326 99.717 -0.411
201602 -0.096 99.317 -0.122
201605 -0.106 100.617 -0.133
201608 -0.125 101.017 -0.156
201611 -0.173 100.517 -0.216
201702 -0.150 101.217 -0.186
201705 -0.163 101.817 -0.201
201708 -0.230 102.617 -0.282
201711 -0.210 102.117 -0.259
201802 -0.090 102.317 -0.111
201805 -0.082 103.917 -0.099
201808 -0.096 104.517 -0.116
201811 -0.151 104.217 -0.182
201902 -0.110 103.817 -0.133
201905 -0.044 105.418 -0.052
201908 -0.050 106.018 -0.059
201911 -0.160 105.318 -0.191
202002 -0.160 105.618 -0.191
202005 -0.170 106.018 -0.202
202008 -0.098 106.018 -0.116
202011 -0.190 105.018 -0.228
202102 -0.200 107.018 -0.235
202105 -0.220 108.170 -0.256
202108 -0.170 109.118 -0.196
202111 -0.213 110.173 -0.243
202202 -0.210 111.754 -0.236
202205 -0.040 115.760 -0.043
202208 -0.135 116.709 -0.145
202211 -0.140 119.872 -0.147
202302 -0.140 121.454 -0.145
202305 -0.200 122.824 -0.205
202308 0.000 123.878 0.000
202311 -0.100 123.668 -0.102
202402 -0.100 124.511 -0.101
202405 -0.090 125.776 -0.090

Add all the adjusted EPS together and divide 10 will get our e10.


Heidelberg Pharma AG  (XTER:HPHA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Heidelberg Pharma AG E10 Related Terms

Thank you for viewing the detailed overview of Heidelberg Pharma AG's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Heidelberg Pharma AG Business Description

Traded in Other Exchanges
Address
Gregor-Mendel-Street 22, Ladenburg, DEU, 68526
Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform and advances the biological mode of action of the toxin as a novel therapeutic principle. The proprietary lead candidate is HDP-101 which is a BCMA (B-cell maturation antigen) - ATAC for multiple myeloma. In addition, the company offers preclinical contract research services. It operates through the following business divisions: Customer Specific Research, Diagnostics, and TherapeuticS.
Executives
Prof. Dr. Andreas Pahl Board of Directors

Heidelberg Pharma AG Headlines

No Headlines